Cargando…

The necessity for full ventricular coverage with noncontrast T1 mapping in hypertrophic cardiomyopathy

Detalles Bibliográficos
Autores principales:	Rowin, Ethan, Maron, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559292/ https://www.ncbi.nlm.nih.gov/pubmed/23452865 http://dx.doi.org/10.1186/1532-429X-15-S1-E1

Ejemplares similares

Noncontrast T1 values do not correlate to clinically relevant variables in patients with hypertrophic cardiomyopathy
por: Rowin, Ethan, et al.
Publicado: (2013)

Differing strategies for sudden death prevention in hypertrophic cardiomyopathy
por: Maron, Martin S, et al.
Publicado: (2023)

Winter Is Coming: The Slippery Slope of Defining Disease and the Implications for Hypertrophic Cardiomyopathy
por: Rowin, Ethan J., et al.
Publicado: (2022)

Is Hypertrophic Cardiomyopathy Always a Familial and Inherited Disease?
por: Bonaventura, Jiri, et al.
Publicado: (2023)

What Causes Hypertrophic Cardiomyopathy?
por: Maron, Bradley A., et al.
Publicado: (2022)

T(1) mapping for characterization of myocardial fibrosis in hypertrophic cardiomyopathy
por: Liu, Ying, et al.
Publicado: (2016)

Machine Learning for Predicting Heart Failure Progression in Hypertrophic Cardiomyopathy
por: Fahmy, Ahmed S., et al.
Publicado: (2021)

Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience
por: Weinstock, Jonathan, et al.
Publicado: (2016)

Future Role of New Negative Inotropic Agents in the Era of Established Surgical Myectomy for Symptomatic Obstructive Hypertrophic Cardiomyopathy
por: Maron, Barry J., et al.
Publicado: (2022)

Radiomics and deep learning for myocardial scar screening in hypertrophic cardiomyopathy
por: Fahmy, Ahmed S., et al.
Publicado: (2022)

Analysis of risk stratification and prevention of sudden death in pediatric patients with hypertrophic cardiomyopathy: Dilemmas and clarity
por: Bonaventura, Jiri, et al.
Publicado: (2023)

Diffuse Myocardial Fibrosis detected by Multi-slice T(1) Mapping using Slice Interleaved T(1) (STONE) Sequence in Patients with Hypertrophic Cardiomyopathy
por: Kato, Shingo, et al.
Publicado: (2016)

Echocardiographic profiles in hypertrophic cardiomyopathy: imaging beyond the septum and systolic anterior motion
por: Pandian, Natesa G, et al.
Publicado: (2015)

Impact of Sex on Clinical Course and Survival in the Contemporary Treatment Era for Hypertrophic Cardiomyopathy
por: Rowin, Ethan J., et al.
Publicado: (2019)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

Presence Of Left Ventricular Non Compaction In Hypertrophic Cardiomyopathy Is Associated With Arrhythmia
por: Gnanappa, Ganesh Kumar, et al.
Publicado: (2016)

Comparison of look-locker and MOLLI sequences for T1 mapping in hypertrophic and ischemic cardiomyopathy
por: Zhou, Xiaopeng, et al.
Publicado: (2013)

Native T1 mapping in children and young adults with hypertrophic cardiomyopathy
por: Parekh, Keyur, et al.
Publicado: (2016)

Potential value of T1 mapping in cardiac MR assessment of hypertrophic cardiomyopathy and dilated cardiomyopathy patients: preliminary results
por: Jacquier, Alexis, et al.
Publicado: (2012)

Late gadolinium enhancement is compatible with advanced age in hypertrophic cardiomyopathy: implications for risk stratification of sudden death
por: Chan, Raymond H, et al.
Publicado: (2012)

Thinking Outside the Heart to Treat Atrial Fibrillation in Hypertrophic Cardiomyopathy
por: Rowin, Ethan J., et al.
Publicado: (2020)

Variable myocardial interstitial expansion by T1 mapping within LGE area in infarction and hypertrophic cardiomyopathy
por: Maestrini, Viviana, et al.
Publicado: (2013)

Role of inflammation in the pathogenesis of hypertrophic cardiomyopathy: a T2-mapping CMR study
por: Ismail, Tevfik F, et al.
Publicado: (2012)

Global circumferential left ventricular strain impairment in hypertrophic cardiomyopathy: comparison to left ventricular hypertrophy and late gadolinium enhancement
por: Macron, Laurent, et al.
Publicado: (2013)

Rat heart T2-mapping with full coverage of the left ventricle myocardium
por: Johansson, Edvin, et al.
Publicado: (2016)

Maximal left ventricular wall thickness: a comparison between CMR and echocardiography in hypertrophic cardiomyopathy
por: Corona-Villalobos, Celia P, et al.
Publicado: (2013)

Non-contrast T1rho CMR for hypertrophic cardiomyopathy
por: Wang, Chunhua, et al.
Publicado: (2015)

Efficacy of Novel Noncontrast Cardiac Magnetic Resonance Methods in Indicating Fibrosis in Hypertrophic Cardiomyopathy
por: Sharifian, Maedeh, et al.
Publicado: (2021)

Evaluation of left ventricular outflow tract obstruction with 4D phase contrast in patients with hypertrophic cardiomyopathy
por: Chu, Linda, et al.
Publicado: (2014)

Myocardial triglyceride content in patients with left ventricular hypertrophy: comparison between hypertensive heart and hypertrophic cardiomyopathy
por: Sai, Eiryu, et al.
Publicado: (2015)

Altered intercellular communication and extracellular matrix signaling as a potential disease mechanism in human hypertrophic cardiomyopathy
por: Larson, Amy, et al.
Publicado: (2022)

Right ventricular T1 mapping is technically feasible and correlates with right ventricular dysfunction in non-ischemic cardiomyopathy
por: Jellis, Christine, et al.
Publicado: (2014)

Native T1 is predictive of abnormal myocardial strain in hypertrophic cardiomyopathy
por: Jensen, Patrick J, et al.
Publicado: (2015)

Clinical Characteristics and Healthcare Resource Utilization among Patients with Obstructive Hypertrophic Cardiomyopathy Treated in a Range of Settings in the United States
por: Butzner, Michael, et al.
Publicado: (2022)

CMR assessment of hypertrophic cardiomyopathy with restrictive phenotype
por: Lu, Minjie, et al.
Publicado: (2015)

T1 mapping in discrimination between hypertrophic and hypertensive cardiomyopathy
por: Hinojar, Rocio, et al.
Publicado: (2014)

A novel cardiac magnetic resonance imaging technique to evaluate left ventricular diastolic function in patients with hypertrophic cardiomyopathy
por: Saba, Shahryar G, et al.
Publicado: (2012)

Mitral valve leaflet length as an important factor to differentiate hypertrophic cardiomyopathy from other causes of left ventricular hypertrophy
por: Luo, Yong, et al.
Publicado: (2016)

Gene database for the development of genetic testing for hypertrophic cardiomyopathy
por: Silas, Justin Carlus, et al.
Publicado: (2014)

The clinical and CMR Characteristics of Hypertrophic Cardiomyopathy with Restrictive Phenotype
por: Lu, Minjie, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_e00pev2plh5bsgunvfps96bnnh